We report a case of a 71-year-old female with trichoblastic fibroma, a rare benign tumor of the skin, found in the left breast, associated with an invasive contralateral breast cancer. On clinical examination, a solitary, firm nodule was found in the subcutaneous tissue of the left breast with no changes in the overlying skin. Radiological examination showed disconcordant results. Conventional mammography and ultrasound suggested benign nature, while magnetic resonance mammography and spectroscopy raised the presumption of the malignant nature of the lesion. After performing excisional biopsy, the diagnosis of trichoblastic fibroma was established. Microscopically, it was composed of fibrous stroma, basaloid germs and strands and lace-like epithelial components, with no obvious connection with overlying epithelium or adjacent adnexal structures.
Introduction


Adnexal skin tumors are a heterogeneous group of rare tumors, especially arising from skin overlying the breast parenchyma. This type of tumor sometimes can be difficult to diagnose without histology, because of wide variety of clinical presentations [1] [2] [3] [4] .Cases of apocrine poroma, syringomatous adenoma of the nipple, cylindroma, hidradenoma, syringocystadenoma papilliferum, pilomatrixoma have been reported [1, 2, [4] [5] [6] [7] [8] [9] [10] [11] . To the best of our knowledge, only one case of trichoblastic tumor in the skin of the breast has been reported up to now [12] .
The role of MR (magnetic-resonance) imaging in diagnosis of breast pathology has increased over the past decade. Breast MRM (MR mammography) is the most sensitive modality for invasive breast cancer detection, but it has limited specificity usually leading to unnecesary biopsies. A study by Liberman et al. [13] showed that MR imaging detected cancer that was not visible on physical examination and mammography in the contralateral breast in 5% of women recently diagnosed with breast cancer. MRM increases detection of mammographically or ultrasonographically occult lesions in ipsilateral or contralateral breast, but the actual clinical impact of these incidental cancers is unknown [14] . Modern MRM protocols include pharmacokinetic modeling, DWI (diffusion-weighted imaging) and MRS (MR spectroscopy). MRS can be detected with choline that is precursor of the phospholipids composing cell membranes. Increase in choline peak reflects increased membrane metabolism and/or degradation, thus enabling differentiation between benign and malignant lesions and serving as an indicator of tumor activity and viability [15] [16] [17] development. MR spectroscopy has been suggested as an adjunct to the breast MR imaging to distinguish benign from malignant breast lesions [23, 24] .Elevated Cho compounds are thought to be a marker of an active tumor in the breast with reported sensitivity of 70-100% and specificity of 67-100% [25, 26] .
Reviewing the literature, we have not found any previous reports on the in vivo MRS findings of trichoblastic fibroma. Although trichoblastic fibroma represents a benign skin tumor, it presented an elevated Cho peak characteristic for malignant lesions. The aberrant choline metabolism is established as universal metabolic indicator of cancer. However, MRS of the breast is a diagnostic modality still in progress, indicating that quantification of choline compounds may lead to increased reliability in differentiation of breast tumors [27] [28] [29] .
Namely in our patient, the presence of choline, regardless of concentration, was proven to be misleading, probably due to mesenchymal origin of the tumor [25] . Radiological diagnosis of the breast lesion should take into account both morphologic and dynamic features of the mass, and lead to a comprehensive and clinically useful conclusion. However, when considering a breast lesion, one should bear in mind that, although rarely, in breast tissues other than glandular benignant and malignant tumors can also be found.
Conclusions
In conclusion, further improvement of MRM and MRS in breast pathology is needed to increase the specificity of these imaging modalities. On the other hand, research on the molecular basis of the association between the skin changes and internal cancer, as well as the recognition of these cutaneous signs and symptoms independent of malignancy should eventually help the clinician to establish a correct diagnosis [30, 31] .
